65 related articles for article (PubMed ID: 38612630)
21. Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity.
Qu T; Zhong T; Pang X; Huang Z; Jin C; Wang ZM; Li B; Xia Y
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450383
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data.
Son J; Hsieh RC; Lin HY; Krause KJ; Yuan Y; Biter AB; Welsh J; Curran MA; Hong DS
Front Immunol; 2022; 13():1027235. PubMed ID: 36439116
[TBL] [Abstract][Full Text] [Related]
23. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.
Ju WT; Xia RH; Zhu DW; Dou SJ; Zhu GP; Dong MJ; Wang LZ; Sun Q; Zhao TC; Zhou ZH; Liang SY; Huang YY; Tang Y; Wu SC; Xia J; Chen SQ; Bai YZ; Li J; Zhu Q; Zhong LP
Nat Commun; 2022 Sep; 13(1):5378. PubMed ID: 36104359
[TBL] [Abstract][Full Text] [Related]
24. The niche-specialist and age-related oral microbial ecosystem: crosstalk with host immune cells in homeostasis.
Lin D; Hu Q; Yang L; Zeng X; Xiao Y; Wang D; Dai W; Lu H; Fang J; Tang Z; Wang Z
Microb Genom; 2022 Jun; 8(6):. PubMed ID: 35731208
[TBL] [Abstract][Full Text] [Related]
25. Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Wise-Draper TM; Gulati S; Palackdharry S; Hinrichs BH; Worden FP; Old MO; Dunlap NE; Kaczmar JM; Patil Y; Riaz MK; Tang A; Mark J; Zender C; Gillenwater AM; Bell D; Kurtzweil N; Mathews M; Allen CL; Mierzwa ML; Casper K; Jandarov R; Medvedovic M; Lee JJ; Harun N; Takiar V; Gillison M
Clin Cancer Res; 2022 Apr; 28(7):1345-1352. PubMed ID: 35338369
[TBL] [Abstract][Full Text] [Related]
26. The foundations of immune checkpoint blockade and the ipilimumab approval decennial.
Korman AJ; Garrett-Thomson SC; Lonberg N
Nat Rev Drug Discov; 2022 Jul; 21(7):509-528. PubMed ID: 34937915
[TBL] [Abstract][Full Text] [Related]
27. Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study.
Fukumoto C; Oshima R; Sawatani Y; Shiraishi R; Hyodo T; Kamimura R; Hasegawa T; Komiyama Y; Izumi S; Fujita A; Wakui T; Kawamata H
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830994
[TBL] [Abstract][Full Text] [Related]
28. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
[TBL] [Abstract][Full Text] [Related]
29. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of cetuximab as preemptive postsurgical therapy for oral squamous cell carcinoma patients with major risk: a single-center retrospective cohort study.
Fukumoto C; Sawatani Y; Shiraishi R; Zama M; Shimura M; Hasegawa T; Komiyama Y; Fujita A; Wakui T; Kawamata H
Invest New Drugs; 2021 Jun; 39(3):846-852. PubMed ID: 33449240
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics, treatment methods and prognoses of patients with oral squamous cell carcinoma in Japanese population: a single institution retrospective cohort study.
Fukumoto C; Ogisawa S; Tani M; Hyodo T; Kamimura R; Sawatani Y; Hasegawa T; Komiyama Y; Fujita A; Wakui T; Haruyama Y; Kobashi G; Kawamata H
BMC Geriatr; 2020 Nov; 20(1):487. PubMed ID: 33218306
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
Schoenfeld JD; Hanna GJ; Jo VY; Rawal B; Chen YH; Catalano PS; Lako A; Ciantra Z; Weirather JL; Criscitiello S; Luoma A; Chau N; Lorch J; Kass JI; Annino D; Goguen L; Desai A; Ross B; Shah HJ; Jacene HA; Margalit DN; Tishler RB; Wucherpfennig KW; Rodig SJ; Uppaluri R; Haddad RI
JAMA Oncol; 2020 Oct; 6(10):1563-1570. PubMed ID: 32852531
[TBL] [Abstract][Full Text] [Related]
33. Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.
Kujan O; van Schaijik B; Farah CS
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708945
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant checkpoint blockade for cancer immunotherapy.
Topalian SL; Taube JM; Pardoll DM
Science; 2020 Jan; 367(6477):. PubMed ID: 32001626
[TBL] [Abstract][Full Text] [Related]
35. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Basté N; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Wan Ishak WZ; Hong RL; González Mendoza R; Roy A; Zhang Y; Gumuscu B; Cheng JD; Jin F; Rischin D;
Lancet; 2019 Nov; 394(10212):1915-1928. PubMed ID: 31679945
[TBL] [Abstract][Full Text] [Related]
36. The role of keratins in modulating carcinogenesis via communication with cells of the immune system.
Sequeira I; Watt FM
Cell Stress; 2019 Mar; 3(4):136-138. PubMed ID: 31225508
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
Matoba T; Imai M; Ohkura N; Kawakita D; Ijichi K; Toyama T; Morita A; Murakami S; Sakaguchi S; Yamazaki S
Int J Cancer; 2019 Jun; 144(11):2811-2822. PubMed ID: 30485427
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic alteration of basal cells in oral lichen planus; switching keratin 19 and desmoglein 1 expression.
Shimada K; Ochiai T; Shen FC; Hasegawa H
J Oral Sci; 2018 Dec; 60(4):507-513. PubMed ID: 30146538
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory role of Keratin 76 in oral and gastric cancer.
Sequeira I; Neves JF; Carrero D; Peng Q; Palasz N; Liakath-Ali K; Lord GM; Morgan PR; Lombardi G; Watt FM
Nat Commun; 2018 Aug; 9(1):3437. PubMed ID: 30143634
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Moskovitz J; Moy J; Ferris RL
Curr Oncol Rep; 2018 Mar; 20(2):22. PubMed ID: 29502288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
